SubHero Banner
Text

Kanjinti (trastuzumab-anns) – New biosimilar approval

June 13, 2019 - Amgen and Allergan announced the FDA approval of Kanjinti (trastuzumab-anns), a biosimilar to Genentech’s Herceptin® (trastuzumab).

Download PDF